J&J bags option on AdoRx lung cancer drugs

J&J bags option on AdoRx lung cancer drugs

Source: 
Fierce Biotech
snippet: 

Johnson & Johnson Is teaming up with AdoRx Therapeutics to develop lung cancer drugs. The deal gives J&J an exclusive option to research, develop and commercialize AdoRx antagonists.